The U.S. Food and Drug Administration issued Emergency Use Authorization to Illinois-based medical device maker Abbott Labs for a coronavirus test that delivers positive results in as little as five minutes and negative results in 13 minutes, the company said.
The company expects the tests to be available next week and expects to ramp up manufacturing to deliver 50,000 tests per day.
"I am pleased that the FDA authorized Abbott's point of care test yesterday. This is big news and will help get more of these tests out in the field rapidly," said FDA Commissioner Steve Hahn in a statement.
"We know how important it is to get point of care tests out in the field quickly. These tests that can give results quickly can be a game changer in diagnosing COVID-19."
This test is revolutionary in many aspects
*Quick test and results.
*Less contact between healthcare providers, patients and other patients in the ER.
"We know how important it is to get point of care tests out in the field quickly. These tests that can give results quickly can be a game changer in diagnosing COVID-19."
This test is revolutionary in many aspects
*Quick test and results.
*Less contact between healthcare providers, patients and other patients in the ER.
No comments:
Post a Comment